Major depressive disorder (MDD) is a leading cause of disability worldwide, with a significant proportion of patients (10-20%) progressing to treatment-resistant depression (TRD).

Ketamine, a non-competitive N-methyl-D-aspartate receptor antagonist, has emerged as an effective therapeutic agent for the management of treatment-resistant depression. Repeated treatments with ...

IntroductionMajor depressive disorder (MDD) is a leading cause of disability worldwide, with a significant proportion of patients (10-20%) progressing ...

A Calgary clinic has received provisional accreditation to provide a novel way of administering the psychedelic drug ketamine ...

Bryan Johnson, the American entrepreneur renowned for his anti-ageing endeavours, has disclosed the details of his latest ...

B-2D, a brain receptor targeted by ketamine. Using cryo-EM, they visualize how ketamine binds to the receptor, controlling ...

The drug is approved for use by doctors and veterinarians as an anesthetic—but is also capable of producing hallucinogenic ...

Ketamine has received a Hollywood makeover. It used to be known as a rave drug (street name special K) and cat anesthetic.

Tech mogul Bryan Johnson, known for his radical anti-aging methods, admitted to injecting himself with Ketamine, a horse ...

A Hollywood Tragedy,' which focuses on a criminal investigation and charges brought after the actor’s death in October 2023.

We’re with Dr. Handoo, one of the most experienced psychiatrists in the country for treatment-resistant depression. He ...

A recent case report published in the Journal of Psychoactive Drugs tells the story of a middle-aged man who underwent an ...